心臟成纖維細(xì)胞為心肌細(xì)胞提供結(jié)構(gòu)支持，并負(fù)責(zé)在生長(zhǎng)和病理生理?xiàng)l件下心肌細(xì)胞外基質(zhì)的合成。CF是心肌損傷反應(yīng)的重要細(xì)胞成分和旁分泌生長(zhǎng)因子的來(lái)源。CF的增殖和基質(zhì)合成對(duì)于心肌梗塞、心肌纖維化部位瘢痕形成具有重要作用。CF的培養(yǎng)已被廣泛應(yīng)用為生理（運(yùn)動(dòng)）和病理（高血壓）應(yīng)激下心臟基質(zhì)重塑研究的模型。
Sciencell研究實(shí)驗(yàn)室的HCF是從人心臟分離得到的，原代凍存，冰凍運(yùn)輸。每管細(xì)胞密度超過(guò)5×10^5/ml。細(xì)胞特性經(jīng)纖維粘連蛋白免疫熒光鑒定。本細(xì)胞經(jīng)檢測(cè)不含HIV-1、HBV、HCV、支原體、細(xì)菌、酵母菌和真菌。如采用ScienCell 實(shí)驗(yàn)室特制的培養(yǎng)基，可保證此細(xì)胞15倍增增殖。
推薦培養(yǎng)基：成纖維細(xì)胞培養(yǎng)基-2FM-2 (2FM-2, Cat. #2331)
|
貨號(hào)
|
6300
|
|
產(chǎn)地
|
美國(guó)
|
|
縮寫(xiě)
|
HCF
|
|
規(guī)格
|
5 x 10^5 /1ml
|
|
用途
|
科研
|
|
儲(chǔ)存
|
液氮
|
|
運(yùn)輸
|
干冰
|
|
關(guān)鍵字
|
人心臟成纖維細(xì)胞 HCF 人心臟成纖維細(xì)胞 HCF 人心臟成纖維細(xì)胞 HCF 人心臟成纖維細(xì)胞 HCF 人心臟成纖維細(xì)胞 HCF 人心臟成纖維細(xì)胞 HCF
|
公司簡(jiǎn)介
|
合肥星肽生物科技有限公司作為專(zhuān)業(yè)的ScienCell中國(guó)代理商，專(zhuān)業(yè)經(jīng)營(yíng)實(shí)驗(yàn)室科研用原代細(xì)胞、原代細(xì)胞專(zhuān)用培養(yǎng)基、原代細(xì)胞無(wú)血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無(wú)血清培養(yǎng)基的研究和開(kāi)發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù)，對(duì)購(gòu)買(mǎi)項(xiàng)目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項(xiàng)目準(zhǔn)確到位，都有相關(guān)專(zhuān)業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)！
|
|
聯(lián)系方式
|
何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://www.83pc.cn QQ:514713116
|
1.) Chida J, Araki H, Maeda Y. (2014) "Specific growth suppression of human cancer cells by targeted delivery of Dictyostelium mitochondrial ribosomal protein S4." Cancer cell int. 14: 56.
2.) Huntley BK, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC Jr. (2010) "B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts." J Cell Physiol. 225: 251-5.
3.) Lin CS, Pan CH, Wen CH, Yang TH, Kuan TC. (2010) "Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts." Peptides. 31: 1334-40.
4.) Westenbrink BD, Ruifrok WP, Voors AA, Tilton RG, van Veldhuisen DJ, Schoemaker RG, van Gilst WH, de Boer RA. (2010) "Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure." Cardiovasc Res. 87: 30-9.
5.) Huntley BK, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC. (2010) "B?type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts." J of cell physiol. 225: 251-55.
6.) McKie PM, Cataliotti A, Huntley BK, Martin FL, Olson TM, Burnett JC Jr. (2009) "A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions." J Am Coll Cardiol. 54: 1024-32.
7.) Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC Jr. (2008) "Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP." J Am Coll Cardiol. 52: 60-8.
8.) Pan CH, Wen CH, Lin CS. (2008) "Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes." Exp Physiol. 93: 599-612.
9.) Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, Kim IS, Valente AJ, Chandrasekar B. (2008) "Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation." J Cell Physiol. 215: 697-707.
10.) Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D. (2008) "Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction." Circulation. 117: 2224-31.
11.) Bunda S, Liu P, Wang Y, Liu K, Hinek A. (2007) "Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner." Am J Pathol. 171: 809-19.
12.) Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B. (2007) "IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation." Am J Physiol Heart Circ Physiol. 293: H3356-65.
13.) Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW, Ikeda Y. (2007) "The RAS/Raf1/MEK/ERK Signaling Pathway Facilitates VSV-mediated Oncolysis: Impli cation for the Defective Interferon Response in Cancer Cells." Mol Ther. 15: 1531-6.
14.) Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y, Burnett JC Jr. (2006) "BNP-induced activation of cGMP in human cardiac fibroblasts: Interactions with fibronectin and natriuretic peptide receptors." J Cell Physiol. 209: 943-9.
There are no product questions yet.
